BBP vs. FTXH
Compare and contrast key facts about Virtus LifeSci Biotech Products ETF (BBP) and First Trust Nasdaq Pharmaceuticals ETF (FTXH).
BBP and FTXH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBP is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Products Index. It was launched on Dec 17, 2014. FTXH is a passively managed fund by First Trust that tracks the performance of the Nasdaq U.S. Smart Pharmaceuticals Index. It was launched on Sep 20, 2016. Both BBP and FTXH are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBP or FTXH.
Key characteristics
| BBP | FTXH | |
|---|---|---|
| YTD Return | -4.44% | 0.38% |
| 1Y Return | 4.53% | 2.26% |
| 3Y Return (Ann) | 2.31% | 2.61% |
| 5Y Return (Ann) | 5.47% | 6.00% |
| Sharpe Ratio | 0.23 | 0.12 |
| Daily Std Dev | 22.51% | 12.58% |
| Max Drawdown | -44.32% | -32.11% |
| Current Drawdown | -12.06% | -5.73% |
Correlation
The correlation between BBP and FTXH is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BBP vs. FTXH - Performance Comparison
In the year-to-date period, BBP achieves a -4.44% return, which is significantly lower than FTXH's 0.38% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BBP vs. FTXH - Expense Ratio Comparison
BBP has a 0.79% expense ratio, which is higher than FTXH's 0.60% expense ratio.
Risk-Adjusted Performance
BBP vs. FTXH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BBP vs. FTXH - Dividend Comparison
BBP has not paid dividends to shareholders, while FTXH's dividend yield for the trailing twelve months is around 1.43%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.43% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.16% | 0.00% |
Drawdowns
BBP vs. FTXH - Drawdown Comparison
The maximum BBP drawdown since its inception was -44.32%, which is greater than FTXH's maximum drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for BBP and FTXH. For additional features, visit the drawdowns tool.
Volatility
BBP vs. FTXH - Volatility Comparison
Virtus LifeSci Biotech Products ETF (BBP) has a higher volatility of 6.94% compared to First Trust Nasdaq Pharmaceuticals ETF (FTXH) at 3.87%. This indicates that BBP's price experiences larger fluctuations and is considered to be riskier than FTXH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.